Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
T P Hughes; B Leber; F Cervantes; N Spector; R Pasquini; N CD Clementino; A P Schwarer; P E Dorlhiac-Llacer; F-X Mahon; D Rea; A Guerci-Bresler; S Kamel-Reid; I Bendit; S Acharya; T Glynos; D Dalal; S Branford; J H Lipton
Author Information: Division of Haematology, SA Pathology and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, South Australia, Australia;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.